Case number 1:23-cv-00704
Apotex Inc. v. Boehringer lngelheim Pharmaceuticals, Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 11, 2023 | 25 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # 1 Consent Decree and Judgment)(mdb) (Entered: 10/11/2023) (0) |
| Oct 11, 2023 | 24 | Official Transcript of Teleconference held on 09/06/2023 before Judge Maryellen Noreika. Court Reporter/Transcriber Dale C. Hawkins,Email: Dale_Hawkins@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 11/1/2023. Redacted Transcript Deadline set for 11/13/2023. Release of Transcript Restriction set for 1/9/2024. (dh) (Entered: 10/11/2023) (7) |
| Oct 10, 2023 | 23 | CONSENT DECREE AND FINAL JUDGMENT. Signed by Judge Maryellen Noreika on 10/10/2023. (dlw) (Entered: 10/10/2023) (4) |
| Oct 5, 2023 | 22 | Letter to the Honorable Maryellen Noreika from John C. Phillips, Jr. regarding the parties' proposed Consent Decree and Final Judgment. (Attachments: # 1 Exhibit A)(Haney, Megan) (Entered: 10/05/2023) (0) |
| Sep 6, 2023 | N/A | Minute Entry for proceedings held before Judge Maryellen Noreika - Telephone Conference held on 9/6/2023 re Proposed Consent Judgment ( 18 ). The parties shall confer and submit a revised version that is in accordance with the Court's directives on the call. (Court Reporter Dale Hawkins.) (mdb) (Entered: 09/06/2023) (0) |
| Sep 5, 2023 | 21 | ORAL ORDER re 18 Proposed Consent Judgment - IT IS HEREBY ORDERED that the TIME of the 9/6/2023 teleconference is RESET for 10:00 AM. ORDERED by Judge Maryellen Noreika on 9/5/2023. (mdb) (Entered: 09/05/2023) (0) |
| Aug 29, 2023 | 20 | ORAL ORDER RESETTING Teleconference - IT IS HEREBY ORDERED that the 8/30/2023 teleconference is RESET for 9/6/2023 at 01:00 PM before Judge Maryellen Noreika. ORDERED by Judge Maryellen Noreika on 8/29/2023. (dlw) (Entered: 08/29/2023) (0) |
| Aug 28, 2023 | 19 | ORAL ORDER Setting Teleconference re 18 Proposed Consent Judgment - IT IS HEREBY ORDERED that a Telephone Conference is set for 8/30/2023 at 10:00 AM before Judge Maryellen Noreika. Counsel shall provide a teleconference dial-in number and code for the teleconference by emailing this Court's judicial administrator. ORDERED by Judge Maryellen Noreika on 8/28/2023. (dlw) (Entered: 08/28/2023) (0) |
| Aug 25, 2023 | 18 | PROPOSED CONSENT JUDGMENT by Apotex Inc.. (Phillips, John) (Entered: 08/25/2023) (4) |
| Aug 18, 2023 | N/A | SO ORDERED, re 17 STIPULATION TO EXTEND TIME for Defendants to respond to the Complaint (D.I. 2 ) to August 25, 2023. Set/Reset Answer Deadlines: Boehringer lngelheim Corporation answer due 8/25/2023; Boehringer lngelheim International GMBH answer due 8/25/2023; Boehringer lngelheim Pharma GMBH & Co.KG. answer due 8/25/2023; Boehringer lngelheim Pharmaceuticals, Inc. answer due 8/25/2023. ORDERED by Judge Maryellen Noreika on 8/18/2023. (mdb) (Entered: 08/18/2023) (0) |
| Aug 18, 2023 | 17 | STIPULATION TO EXTEND TIME for Defendants to respond to the Complaint (D.I. 2) to August 25, 2023 - filed by Boehringer lngelheim Corporation, Boehringer lngelheim International GMBH, Boehringer lngelheim Pharma GMBH & Co.KG., Boehringer lngelheim Pharmaceuticals, Inc.. (Dellinger, Megan) (Entered: 08/18/2023) (2) |
| Aug 14, 2023 | N/A | SO ORDERED re 16 STIPULATION TO EXTEND TIME for Boehringer to respond to Apotex's Complaint (D.I. 2) to August 18, 2023 (Set/Reset Answer Deadlines: Boehringer lngelheim Corporation answer due 8/18/2023; Boehringer lngelheim International GMBH answer due 8/18/2023; Boehringer lngelheim Pharma GMBH & Co.KG. answer due 8/18/2023; Boehringer lngelheim Pharmaceuticals, Inc. answer due 8/18/2023). ORDERED by Judge Maryellen Noreika on 8/14/2023. (dlw) (Entered: 08/14/2023) (0) |
| Aug 11, 2023 | 16 | STIPULATION TO EXTEND TIME for Boehringer to respond to Apotex's Complaint (D.I. 2) to August 18, 2023 - filed by Boehringer lngelheim Corporation, Boehringer lngelheim International GMBH, Boehringer lngelheim Pharma GMBH & Co.KG., Boehringer lngelheim Pharmaceuticals, Inc.. (Blumenfeld, Jack) (Entered: 08/11/2023) (2) |
| Aug 8, 2023 | N/A | Pro Hac Vice Attorney Rachel P. Waldron for Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mkr) (Entered: 08/08/2023) (0) |
| Aug 8, 2023 | N/A | Pro Hac Vice Attorney Greg L. Goldblatt for Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mkr) (Entered: 08/08/2023) (0) |
| Aug 8, 2023 | N/A | SO ORDERED re 15 MOTION for Pro Hac Vice Appearance of Attorney Rachel Pernic Waldron and Greg L. Goldblatt filed by Apotex Inc. ORDERED by Judge Maryellen Noreika on 8/8/2023. (dlw) (Entered: 08/08/2023) (0) |
| Aug 7, 2023 | 15 | MOTION for Pro Hac Vice Appearance of Attorney Rachel Pernic Waldron and Greg L. Goldblatt - filed by Apotex Inc.. (Attachments: # 1 Certification of Rachel Pernic Waldron, # 2 Certification of Greg L. Goldblatt)(Haney, Megan) (Entered: 08/07/2023) (0) |
| Aug 4, 2023 | N/A | Pro Hac Vice Attorney William A. Rakoczy for Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mkr) (Entered: 08/04/2023) (0) |
| Aug 2, 2023 | N/A | SO ORDERED, re 14 MOTION for Pro Hac Vice Appearance of Attorney William A. Rakoczy and Steven J. Birkos filed by Apotex Inc.. ORDERED by Judge Maryellen Noreika on 8/2/2023. (mdb) (Entered: 08/02/2023) (0) |
| Aug 1, 2023 | 14 | MOTION for Pro Hac Vice Appearance of Attorney William A. Rakoczy and Steven J. Birkos - filed by Apotex Inc.. (Attachments: # 1 Certification of William A. Rakoczy, # 2 Certification of Steven J. Birkos)(Haney, Megan) (Entered: 08/01/2023) (0) |
| Jul 27, 2023 | N/A | SO ORDERED re 13 STIPULATION TO EXTEND TIME for Boehringer to respond to Apotex's Complaint (D.I. 2) to August 11, 2023 (Set/Reset Answer Deadlines: Boehringer lngelheim Corporation answer due 8/11/2023; Boehringer lngelheim International GMBH answer due 8/11/2023; Boehringer lngelheim Pharma GMBH & Co.KG. answer due 8/11/2023; Boehringer lngelheim Pharmaceuticals, Inc. answer due 8/11/2023). ORDERED by Judge Maryellen Noreika on 7/27/2023. (dlw) (Entered: 07/27/2023) (0) |
| Jul 26, 2023 | 13 | STIPULATION TO EXTEND TIME for Boehringer to respond to Apotex's Complaint (D.I. 2) to August 11, 2023 - filed by Boehringer lngelheim Corporation, Boehringer lngelheim International GMBH, Boehringer lngelheim Pharma GMBH & Co.KG., Boehringer lngelheim Pharmaceuticals, Inc.. (Egan, Brian) (Entered: 07/26/2023) (2) |
| Jul 10, 2023 | 12 | SUMMONS Returned Executed by Apotex Inc..Boehringer lngelheim International GMBH served on 7/7/2023, answer due 7/28/2023. (Haney, Megan) (Entered: 07/10/2023) (2) |
| Jul 10, 2023 | 11 | SUMMONS Returned Executed by Apotex Inc..Boehringer lngelheim Pharma GMBH & Co.KG. served on 7/7/2023, answer due 7/28/2023. (Haney, Megan) (Entered: 07/10/2023) (2) |
| Jul 10, 2023 | 10 | AFFIDAVIT of Service for Complaint, Summons and Related Papers served on Boehringer Ingelheim Corporation and Boehringer Ingelheim Pharmaceuticals, Inc. on July 5, 2023 and July 6, 2023, filed by Apotex Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D)(Haney, Megan) (Entered: 07/10/2023) (0) |
| Jul 6, 2023 | 9 | REDACTED VERSION of 2 Complaint, by Apotex Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Civil Cover Sheet)(Phillips, John) (Entered: 07/06/2023) (0) |
| Jul 5, 2023 | N/A | Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) (Entered: 07/05/2023) (0) |
| Jun 29, 2023 | N/A | Remark: Case submitted for judicial routine assignment. (vfm) (Entered: 06/30/2023) (0) |
| Jun 29, 2023 | 8 | ORAL ORDER: IT IS HEREBY ORDERED that Plaintiff's Motion for Leave to File the Complaint Under Seal (D.I. 1) is GRANTED. IT IS ALSO HEREBY ORDERED that, no later than Thursday, July 6, 2023, Plaintiff shall file a redacted version of the Complaint. Ordered by Judge Gregory B. Williams on 6/29/2023. (etg) (Entered: 06/29/2023) (0) |
| Jun 28, 2023 | N/A | Remark: Exit electronic copies to Duty Judge GBW. (vfm) (Entered: 06/29/2023) (0) |
| Jun 28, 2023 | 7 | Summons Issued as to Boehringer lngelheim Corporation on 6/28/2023; Boehringer lngelheim International GMBH on 6/28/2023; Boehringer lngelheim Pharma GMBH & Co.KG. on 6/28/2023; Boehringer lngelheim Pharmaceuticals, Inc. on 6/28/2023. (Attachments: # 1 Summons Issued, # 2 Summons Issued, # 3 Summons Issued) (vfm) (Entered: 06/29/2023) (0) |
| Jun 28, 2023 | 6 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Pharmaceutical Holdings Inc., Corporate Parent Artemis Intermediate Holdings, Inc. for Apotex Inc. filed by Apotex Inc.. (vfm) (Entered: 06/29/2023) (2) |
| Jun 28, 2023 | 5 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,673,927 ;8,846,695 ;8,883,805. (vfm) (Entered: 06/29/2023) (1) |
| Jun 28, 2023 | 4 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 05/10/2023. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 11/10/2025. (vfm) (Entered: 06/29/2023) (1) |
| Jun 28, 2023 | 3 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (vfm) (Entered: 06/29/2023) (3) |
| Jun 28, 2023 | 2 | [SEALED] COMPLAINT for ANDA/PATENT INFRINGEMENT filed against Boehringer lngelheim Corporation, Boehringer lngelheim International GMBH, Boehringer lngelheim Pharma GMBH & Co.KG., Boehringer lngelheim Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number 1238.) - filed by Apotex Inc.. (Attachments: # 1 Civil Cover Sheet, # 2 Exhibit A-E) (vfm) (Entered: 06/29/2023) (0) |
| Jun 28, 2023 | 1 | MOTION to Seal - filed by Apotex Inc.. (Attachments: # 1 Text of Proposed Order) (vfm) (Entered: 06/29/2023) (0) |
